Correction to: Digestive Diseases and Sciences (2019) 64:815–822 https://doi.org/10.1007/s10620-018-5365-0
The original version of the article unfortunately contained percentage errors in second and third paragraphs of GerdQ Score section. Below is the corrected version.
We performed a stratified analysis of patients with NERD and erosive esophagitis. The proportions of patients with sufficient relief in NERD were 38.5, 84.6, and 84.6% of 13 patients in the esomeprazole group and 22.2, 66.7, and 77.8% of 9 patients in the vonoprazan group at 1, 2, and 4 weeks, respectively. The proportions of patients with complete resolution in NERD were 23.1, 53.8, and 69.2% in the esomeprazole group and 22.2, 22.2, and 33.3% in the vonoprazan group at 1, 2, and 4 weeks, respectively. There were no significant differences in the rates of sufficient relief and complete resolution in NERD at 1, 2, or 4 weeks between the esomeprazole group and the vonoprazan group.
The proportions of patients with sufficient relief in erosive esophagitis were 66.7, 91.7, and 91.7% of 12 patients in the esomeprazole group and 69.2,76.9, and 84.6% of 13 patients in the vonoprazan group at 1, 2, and 4 weeks, respectively. The proportions of patients with complete resolution in erosive esophagitis were 33.3, 41.7, and 58.3% in the esomeprazole group and 46.2, 46.2, and 61.5% in the vonoprazan group at 1, 2, and 4 weeks, respectively. There were no significant differences in the rates of sufficient relief and complete resolution at 1, 2, or 4 weeks between the esomeprazole group and the vonoprazan group in erosive esophagitis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakurai, K., Suda, H., Fujie, S. et al. Correction to: Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan. Dig Dis Sci 64, 1724 (2019). https://doi.org/10.1007/s10620-019-5464-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-5464-6